ZTALMY 50 mg/ml orale suspensie

{
  "form": "Suspensie voor oraal gebruik",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/ztalmy-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Ganaxolone",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp129092",
  "excipients": [
    "BENZOËZUUR (E 210)",
    "BENZYLALCOHOL (E 1519)",
    "CITROENZUUR 0-WATER (E 330)",
    "GLYCEROLMONOSTEARAAT (E 471)",
    "HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
    "KERSENSMAAKSTOF",
    "MACROGOLSTEARAAT, TYPE I",
    "METHYLCELLULOSE (E 461)",
    "METHYLPARAHYDROXYBENZOAAT (E 218)",
    "NATRIUMBENZOAAT (E 211)",
    "NATRIUMLAURILSULFAAT",
    "POLYSORBAAT 65 (E 436)",
    "POLYVINYLALCOHOL (E 1203)",
    "PROPYLEENGLYCOL (E 1520)",
    "PROPYLPARAHYDROXYBENZOAAT",
    "SIMETICON",
    "SIMETICON EMULSIE",
    "SORBINEZUUR (E 200)",
    "SUCRALOSE (E 955)",
    "WATER, GEZUIVERD",
    "WATER, GEZUIVERD",
    "XANTHAANGOM (E 415)"
  ],
  "substances": [
    "GANAXOLON"
  ],
  "leaflet_url": null,
  "authorised_at": "2023/07/26",
  "procedure_number": "EMEA/H/C/005825",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/23/1743",
  "additional_monitoring": "Y"
}